Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
Titel:
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study
Auteur:
Sulkowski, Mark S. Fessel, Walford J. Lazzarin, Adriano Berenguer, Juan Zakharova, Natalia Cheinquer, Hugo Côté, Pierre Dieterich, Douglas Gadano, Adrian Matthews, Gail Molina, Jean-Michel Moreno, Christophe Pineda, Juan Antonio Pulido, Federico Rivero, Antonio Rockstroh, Jurgen Hernandez, Dennis McPhee, Fiona Eley, Timothy Liu, Zhaohui Mendez, Patricia Hughes, Eric Noviello, Stephanie Ackerman, Peter